VivekKumar IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India

Dr Vivek Kumar is working as Associate Professor of Nephrology at the Postgraduate Institute of Medical Education and Research at Chandigarh in India. His research interests include epidemiology and outcomes in CKD and AKI. He is an India Alliance Clinical and Public Health Intermediate Fellow (Department of Biotechnology, Government of India and Wellcome Trust, UK). He has experience in setting up multi-centric cohort studies and clinical trials in India.

Upload Picture

https://storage.unitedwebnetwork.com/files/1099/5e15360dc5e75ca34cb2b91cf1e8adf3.jpeg

First name

Vivek

Last name

Kumar

Institution

Country

India

Friday, February 7, 2025

Time	Session

9:45 a.m. 11:15 a.m.	Hot Topics From the Tropics YN SabineKaram Chair United StatesUniversity of Minnesota SourabhSharma Chair IndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India Best Abstract Winner - Basic Science: miRNA Profiling of Urinary Exosomes for Predicting Renal Outcome After Acute Kidney Injury: A Pilot Study YN-01 JaskiranKaur Oral Abstract Presenter IndiaDepartment of Experimental Medicine and Biotechnology Best Abstract Winner - Clinical Science: Randomised Controlled Trial Comparing Rituximab to Mycophenolate Mofetil in Children and Young Adults With Steroid-Dependent Idiopathic Nephrotic Syndrome YN-02 AndreaAngeletti Oral Abstract Presenter Italy Q and A YN-03 Everything You Ever Wanted to Know About Tropical Infections and the Kidney YN-04 MythriShankar Speaker IndiaInstitute of Nephrourology Challenges in the Tropics: When CKDu Becomes Less Unknown YN-05 ErangaWijewickrama Speaker Sri LankaFaculty of Medicine, University of Colombo Roundtable Discussion YN-06 BiancaDavidson Speaker South AfricaGroote Schuur Hospital, University of Cape Town ErangaWijewickrama Speaker Sri LankaFaculty of Medicine, University of Colombo MythriShankar Speaker IndiaInstitute of Nephrourology SourabhSharma Speaker IndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India VivekKumar Speaker IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India Champa Hall 304
2:15 p.m. 3:45 p.m.	HIT! High Impact Clinical Trials – What and Why HIT1 AndreaViecelli Chair AustraliaUniversity of Queensland VivekKumar Chair IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE) HIT1-1 RajivAgarwal Oral Abstract Presenter United States Results From the REGENCY Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis HIT1-2 BradRovin Oral Abstract Presenter United StatesThe Ohio State University Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial HIT1-3 KatherineTuttle Oral Abstract Presenter United StatesUniversity of Washington School of Medicine, Division of Nephrology Brahmkamal Hall - Plenary Hall

Saturday, February 8, 2025

Time	Session

9:45 a.m. 11:15 a.m.	Toward Complex Understanding of Kidney Function in AKI: Role of Biomarkers, Sex Differences and the Tropics; ISN-KSN Joint Session IK03 GirishNarayen Chair IndiaChief of Nephrology division, udaiomni hospital, Hyderabad,India Hyeong CheonPark Chair Korea (Republic of)Hyeong Cheon Park, Gangnam Severance Hospital, Yonsei University Prem PVarma Chair IndiaPrincipal Director What Do We Know About the Association Between AKI and Long-Term Adverse Outcomes? IK03-01 Chi-yuanHsu Speaker United StatesUniversity of California, San Francisco Are Biomarkers in AKI Ready for Prime Time? IK03-02 ChiragParikh Speaker United StatesJohns Hopkins University Community-acquired AKI in the Tropics - Is it a Different Disease? IK03-03 VivekKumar Speaker IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India Sex as a Biological Variable in the Epidemiology of AKI IK03-04 MarliesOstermann Speaker United KingdomKing's College London Q&A IK03-05 Amaltas Hall B101-A

Time

Session

9:45 a.m.

11:15 a.m.

Toward Complex Understanding of Kidney Function in AKI: Role of Biomarkers, Sex Differences and the Tropics; ISN-KSN Joint Session

IK03

GirishNarayen Chair IndiaChief of Nephrology division, udaiomni hospital, Hyderabad,India

Hyeong CheonPark Chair Korea (Republic of)Hyeong Cheon Park, Gangnam Severance Hospital, Yonsei University

Prem PVarma Chair IndiaPrincipal Director

What Do We Know About the Association Between AKI and Long-Term Adverse Outcomes?

IK03-01

Chi-yuanHsu Speaker United StatesUniversity of California, San Francisco
Are Biomarkers in AKI Ready for Prime Time?

IK03-02

ChiragParikh Speaker United StatesJohns Hopkins University
Community-acquired AKI in the Tropics - Is it a Different Disease?

IK03-03

VivekKumar Speaker IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India
Sex as a Biological Variable in the Epidemiology of AKI

IK03-04

MarliesOstermann Speaker United KingdomKing's College London
Q&A

IK03-05

Amaltas Hall B101-A